Fennec Pharmaceuticals (FENC) EBITDA Margin (2020 - 2025)
Fennec Pharmaceuticals (FENC) posted EBITDA Margin of 18.54% for Q4 2025, down 1122.34% on a QoQ basis from 1.52% in Q3 2025, and down 675.0% year-over-year from 3.22% in Q4 2024.
Fennec Pharmaceuticals (FENC) EBITDA Margin (2020 - 2025) Analysis & Trends
Fennec Pharmaceuticals' EBITDA Margin history runs 4 years deep, the most recent figure standing at 18.54% for Q4 2025.
- Quarterly EBITDA Margin fell 675.0% year-over-year to 18.54% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 14.07% (down 1948.0% YoY) and the FY2025 annual result came in at 14.07%, down 1947.0% from the prior year.
- EBITDA Margin was 18.54% for Q4 2025 at Fennec Pharmaceuticals, down from 1.52% in the prior quarter.
- Across five years, EBITDA Margin topped out at 54.16% in Q1 2024 and bottomed at 314.25% in Q1 2023.
- A 3-year average of 54.01% and a median of 18.61% in 2023 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2024 — EBITDA Margin jumped 36841 bps — and 2025, when it tumbled 6339 bps.
- Fennec Pharmaceuticals' EBITDA Margin stood at 18.67% in 2023, then soared by 37 bps to 11.79% in 2024, then plunged by 57 bps to 18.54% in 2025.
- Business Quant data shows FENC's EBITDA Margin at 18.54% in Q4 2025, 1.52% in Q3 2025, and 28.31% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 16.51% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 30.35% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Fennec Pharmaceuticals | 287.77 Mn | 250.98 Mn | 12.01 Mn | -18.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -18.54% |
| Sep 30, 2025 | -1.52% |
| Jun 30, 2025 | -28.31% |
| Mar 31, 2025 | -9.23% |
| Dec 31, 2024 | -11.79% |
| Sep 30, 2024 | -74.59% |
| Jun 30, 2024 | -69.39% |
| Mar 31, 2024 | 54.16% |
| Dec 31, 2023 | -18.67% |
| Sep 30, 2023 | -15.61% |
| Jun 30, 2023 | -140.33% |
| Mar 31, 2023 | -314.25% |
| Dec 31, 2020 | -1,673.00% |